TrialDrugs & aging2011

Blood pressure-lowering efficacy of an olmesartan medoxomil/hydrochlorothiazide-based treatment algorithm in elderly patients (age ≥65 years) stratified by age, sex and race: subgroup analysis of a 12-week, open-label, single-arm, dose-titration study.

Joel Neutel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.